F Dabis

Summary

Country: France

Publications

  1. ncbi request reprint 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group.
    F Dabis
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
    Lancet 353:786-92. 1999
  2. ncbi request reprint Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV
    F Dabis
    Unité INSERM no 330, Universite Victor Segalen Bordeaux 2, France
    Health Policy Plan 15:34-42. 2000
  3. ncbi request reprint Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000
    F Dabis
    Unité INSERM no 330, Universite Victor Segalen Bordeaux, France
    AIDS 14:1017-26. 2000
  4. ncbi request reprint Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group
    R Spira
    Unité INSERM U 330, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    Pediatrics 104:e56. 1999
  5. ncbi request reprint 18-Month mortality and perinatal exposure to zidovudine in West Africa
    F Dabis
    Unité INSERM no 330, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS 15:771-9. 2001
  6. ncbi request reprint International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV
    V Leroy
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
    Lancet 352:597-600. 1998
  7. ncbi request reprint [HIV infection in Africa. Clinical and therapeutical research]
    R Salamon
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2
    Presse Med 29:146-52. 2000
  8. ncbi request reprint Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997
    E Malvy
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, Hĵpital Saint André, Centre Hospitalier Universitaire de Bordeaux, France
    J Am Coll Nutr 20:609-15. 2001
  9. pmc Improving child health: the role of research
    F Dabis
    Institut de Santé Publique, d Épidémiologie et de Développement, Case 11, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
    BMJ 324:1444-7. 2002
  10. ncbi request reprint Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99
    R Thiebaut
    Unité INSERM 330, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    HIV Med 2:84-8. 2001

Detail Information

Publications52

  1. ncbi request reprint 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group.
    F Dabis
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
    Lancet 353:786-92. 1999
    ..Zidovudine reduces the rate of vertical transmission of HIV in non-breastfed populations. We assessed the acceptability, tolerance, and 6-month efficacy of a short regimen of oral zidovudine in African populations practising breastfeeding...
  2. ncbi request reprint Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV
    F Dabis
    Unité INSERM no 330, Universite Victor Segalen Bordeaux 2, France
    Health Policy Plan 15:34-42. 2000
    ..The Ghent International Working Group on Mother-to-Child Transmission of HIV developed public health policy options to integrate these interventions into basic and maternal and child health (MCH) services...
  3. ncbi request reprint Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000
    F Dabis
    Unité INSERM no 330, Universite Victor Segalen Bordeaux, France
    AIDS 14:1017-26. 2000
    ..New findings from these trials are now becoming available, the implications of which, for population-based intervention programmes, need urgent consideration...
  4. ncbi request reprint Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group
    R Spira
    Unité INSERM U 330, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    Pediatrics 104:e56. 1999
    ....
  5. ncbi request reprint 18-Month mortality and perinatal exposure to zidovudine in West Africa
    F Dabis
    Unité INSERM no 330, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS 15:771-9. 2001
    ..To study mortality in African children born to HIV-1-infected mothers exposed peripartum to zidovudine...
  6. ncbi request reprint International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV
    V Leroy
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, France
    Lancet 352:597-600. 1998
    ..We aimed to estimate the rate and timing of late postnatal transmission of HIV-1...
  7. ncbi request reprint [HIV infection in Africa. Clinical and therapeutical research]
    R Salamon
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2
    Presse Med 29:146-52. 2000
    ..To illustrate advances and gaps in HIV/AIDS clinical research in Africa, we explored three issues relevant to this research: opportunistic infections in adults, mother-to-child transmission of HIV and the ethical questions...
  8. ncbi request reprint Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997
    E Malvy
    Unité INSERM 330, Universite Victor Segalen Bordeaux 2, Hĵpital Saint André, Centre Hospitalier Universitaire de Bordeaux, France
    J Am Coll Nutr 20:609-15. 2001
    ..To assess the performance of weight related nutritional markers (reported involuntary weight loss greater than 10%, measured weight loss and body mass index-BMI-) in predicting HIV disease progression...
  9. pmc Improving child health: the role of research
    F Dabis
    Institut de Santé Publique, d Épidémiologie et de Développement, Case 11, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
    BMJ 324:1444-7. 2002
  10. ncbi request reprint Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99
    R Thiebaut
    Unité INSERM 330, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    HIV Med 2:84-8. 2001
    ..To estimate the incidence of serum hypertriglyceridaemia > 6 mm/L (HTG) and identify associated factors in the era of highly active antiretroviral therapy (HAART)...
  11. ncbi request reprint Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire
    K Castetbon
    INSERM U 330, Universite Victor Segalen Bordeaux 2, 146 rue de Léo Saignat, 33076 Bordeaux Cedex, France
    Am J Epidemiol 154:75-84. 2001
    ..In Côte d'Ivoire where chemoprophylaxis of opportunistic infections has recently been recommended to be widely initiated on clinical criteria, such thresholds may help to screen patients with higher risks of mortality...
  12. ncbi request reprint HIV prevention in Latin America: reaching youth in Colombia
    F Perez
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, 146, rue Leo Saignat, 33076 Bordeaux, France
    AIDS Care 15:77-87. 2003
    ....
  13. doi request reprint Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort
    M de Pommerol
    INSERM U897 and Institut de Santé Publique d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, France
    Int J STD AIDS 22:67-72. 2011
    ..25; 95% CI = 0.94-5.39). Earlier occurrence of menopause seems to be associated with factors already reported in HIV-negative women (IDU, ethnicity) and with HIV-related immunodeficiency...
  14. ncbi request reprint [Profile of HIV infected patients among blood donors in Abidjan, Côte d'Ivoire (1992-1999)]
    A K Minga
    Projet ANRS 1220, Programme PAC CI, Abidjan, Cote d Ivoire
    Bull Soc Pathol Exot 98:123-6. 2005
    ..Rate of compliance of HIV-infected patients to follow-up has risen to 11% in 1992-1994 to 60% in 1997-1999 and will contribute to reach this aim...
  15. ncbi request reprint Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002
    F Bonnet
    Department of Internal Medicine and Infectious Diseases, Saint Andre Hospital, Bordeaux University Hospital, Bordeaux, France
    HIV Med 6:198-205. 2005
    ..To determine the factors associated with clinical progression (AIDS events and death) in antiretroviral-naive patients who have begun highly active antiretroviral therapy (HAART)...
  16. ncbi request reprint Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002)
    K Martin
    Bordeaux Regional Pharmacovigilance Center, Pharmacology Department, Victor Segalen University, Centre Hospitalier Universitaire, Bordeaux, France
    HIV Med 5:421-6. 2004
    ..Since the inception of highly active antiretroviral therapy (HAART), mortality among HIV-infected patients has decreased, but this has been accompanied by the appearance of several complications...
  17. ncbi request reprint Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients
    D Neau
    Federation of Infectious and Tropical Diseases, Pellegrin Hospital, Place Amelie Raba Leon, 33 076 Bordeaux Cedex, France
    HIV Med 5:171-3. 2004
    ..As observed in patients not infected with HIV, the "anti-HBc-alone" serological profile could reflect essentially late immunity with undetectable anti-HBs antibodies. However, an occult HBV infection cannot be ruled out...
  18. ncbi request reprint Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001
    F Bonnet
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, 1 rue Jean Burguet, 33075 Bordeaux cedex, France
    HIV Med 5:133-9. 2004
    ..To describe the effect and tolerance of lipid-lowering drugs (LLD; fibrates and statins) in patients treated with highly active antiretroviral therapy (HAART)...
  19. ncbi request reprint Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients
    P Mercie
    Internal Medicine and Infectious Diseases, University Hospital of Bordeaux, France
    HIV Med 6:380-7. 2005
    ..In a 12-month follow-up study, we aimed to investigate changes in carotid intima-media thickness (IMT), a surrogate marker of atherosclerosis, and its determinants in HIV-1-infected patients...
  20. ncbi request reprint Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversion
    R Thiebaut
    INSERM E0338 Biostatistics, Bordeaux 2 University, Bordeaux, France
    HIV Med 7:1-9. 2006
    ..To study the determinants of immunological and virological response to highly active antiretroviral therapy (HAART) in naïve patients, adjusting for time since HIV-1 seroconversion...
  21. ncbi request reprint HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002
    A Benard
    INSERM U593, Institut de Santé Publique, d Épidémiologie et de Développement, Bordeaux, France
    Int J Tuberc Lung Dis 10:378-83. 2006
    ..To provide up-to-date and covariate-specific estimates on tobacco smoking prevalence in a representative cohort of French human immunodeficiency virus (HIV) 1 infected patients in 2002...
  22. ncbi request reprint Community-based assessment of infant feeding practices within a programme for prevention of mother-to-child HIV transmission in rural Zimbabwe
    J Orne-Gliemann
    ISPED Zimbabwe, 33 Lawson Avenue, Milton Park, Harare, Zimbabwe
    Public Health Nutr 9:563-9. 2006
    ..To describe the infant feeding practices and attitudes of women who used prevention of mother-to-child transmission of HIV (PMTCT) services in rural Zimbabwe...
  23. ncbi request reprint Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004
    F Bonnet
    CHU de Bordeaux, Services de Médecine Interne et Maladies Infectieuses, Bordeaux, France
    HIV Med 8:547-54. 2007
    ..The aim of the study was to characterize the causes, trends and determinants of severe morbidity in a large cohort of HIV-infected patients between 2000 and 2004...
  24. ncbi request reprint Improved knowledge and practices among end-users of mother-to-child transmission of HIV prevention services in rural Zimbabwe
    J Orne-Gliemann
    Institut de Santé Publique, d Épidémiologie et de Développement, Universite Victor Segalen, Bordeaux 2, Bordeaux, France
    Trop Med Int Health 11:341-9. 2006
    ..To evaluate the influence of a prevention of mother-to-child transmission of HIV advocacy and mobilization campaign on awareness and knowledge levels within the community...
  25. doi request reprint Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study
    Wendy P Bannister
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, United Kingdom
    J Acquir Immune Defic Syndr 48:324-33. 2008
    ..To investigate prevalence of transmitted drug-resistant human immunodeficiency virus (TDR) and factors associated with TDR and to compare virological and CD4 count response to combination antiretroviral therapy...
  26. doi request reprint Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy
    Olivia Peuchant
    Virology Laboratory, Bordeaux University Hospital, Bordeaux, France
    AIDS 22:1417-23. 2008
    ..We investigated the clinical relevance of the detection of majority and minority-resistant variants in an observational study in antiretroviral therapy naive, recently infected patients...
  27. pmc The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds
    J Stover
    Futures Institute, Glastonbury, Connecticut, USA
    Sex Transm Infect 84:i24-i30. 2008
    ....
  28. ncbi request reprint Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa
    D Bonard
    Centre de Diagnostic et de Recherches sur le SIDA, CHU de Treichville, BP V3 Abidjan, Cote d Ivoire, West Africa
    J Acquir Immune Defic Syndr 34:267-73. 2003
    ..Follow-up of infected patients using both markers showed different results. The reliability of the HD p24 Ag assay is questionable for clinical and biologic management as a surrogate tool for measurement of HIV-1 RNA levels in Africa...
  29. ncbi request reprint Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
    G Chene
    Department of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH 3012, Bern, Switzerland
    Lancet 362:679-86. 2003
    ..We examined whether the initial virological and immunological response to highly active antiretroviral treatment (HAART) is prognostic in patients with HIV-1 who start HAART...
  30. ncbi request reprint Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa
    P Combe
    Centre de Diagnostic et de Recherche sur le SIDA, PACCI, Centre Hospitalier Universitaire de Treichville, Abidjan,
    Trans R Soc Trop Med Hyg 95:493-6. 2001
    ..Our results confirm the high prevalence of HIV in Abidjan and the endemic situation of HBV infection. Furthermore, HCV infection is not infrequent in this developing country setting, not explained by sexual transmission...
  31. ncbi request reprint [Impaired fertility in women infected with HIV-1. Implications for sentinel serosurveillance]
    S Yaro
    Centre Muraz, , 01 B.P. 153 Bobo-Dioulasso 01, Burkina Faso
    Rev Epidemiol Sante Publique 49:221-8. 2001
    ..These findings suggest adjusting antenatal clinic-based HIV sentinel surveillance data for age and fertility in order to derive a good estimate of the community HIV prevalence...
  32. ncbi request reprint Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998
    C Marimoutou
    , , 146 rue Leo Saignat, 33076 Bordeaux, France
    J Acquir Immune Defic Syndr 27:161-7. 2001
    ..Based on our results, a high baseline HIV-RNA level is associated with isolated immunologic response; moreover, age should be of importance in treatment decision...
  33. ncbi request reprint Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso
    Y Nebie
    Centre Muraz, Organisation de Coordination et de Coopération pour la lutte contre les Grandes Endémies OCCGE, Bobo Dioulasso, Burkina Faso
    J Acquir Immune Defic Syndr 28:367-72. 2001
    ....
  34. ncbi request reprint Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology
    A Alioum
    INSERM U.330, , , , Bordeaux, France
    Stat Med 20:3539-56. 2001
    ..All estimates should be reported with confidence intervals. This standardized methodology that allows direct comparison between studies is now being applied to four randomized clinical trials...
  35. ncbi request reprint Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999
    F Bonnet
    Fédération de médecine interne, Maladies Infectieuses et Pathologie Tropicale, Hôpital Saint André Bordeaux, France
    HIV Med 3:195-9. 2002
    ..To describe the causes of death in HIV-infected patients in the era of highly active antiretroviral therapy (HAART)...
  36. pmc Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients
    Bernard Masquelier
    Laboratoire de Virologie, Hopital Pellegrin, Bordeaux, France
    Antimicrob Agents Chemother 46:2926-32. 2002
    ..Genotypic and pK parameters should be used to optimize the virological response to LPV/r in PI-experienced patients and to avoid further viral evolution...
  37. ncbi request reprint Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial
    V Leroy
    INSERM U330, ISPED, , Bordeaux, France
    AIDS 15:517-22. 2001
    ..CONCLUSION: High maternal viral load at inclusion strongly predicts MTCT of HIV in Africa. A short ZDV treatment regimen decreases significantly maternal viral load from its pretreatment level...
  38. ncbi request reprint A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999
    F Bonnet
    Fédération de médecine interne, Maladies Infectieuses et Pathologies Tropicales, Hôpital Saint André, Centre Hospitalier Universitaire de Bordeaux, Universite Victor Segalen, Bordeaux, France
    Clin Infect Dis 35:1231-7. 2002
    ..Coinfection with HCV or HBV increased the risk of hepatotoxicity, which lead to the cautious use of nevirapine for such patients...
  39. ncbi request reprint Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997
    C Binquet
    , , , France
    Am J Epidemiol 153:386-93. 2001
    ..The findings support the potential for interruption of certain types of prophylaxis against opportunistic infections under reasonable conditions of duration of antiretroviral therapy and sustained CD4+ cell response...
  40. ncbi request reprint Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997
    S Vandentorren
    INSERM U330, , France
    Eur J Epidemiol 17:7-10. 2001
    ..7% to 72.2% (p = 0.007). CONCLUSION: HAART treatment has reduced the number and percentage of deaths due to AIDS-related causes among persons who died with HIV infection in South-western France...
  41. ncbi request reprint Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'Ivoire
    K Castetbon
    INSERM U.330, , Bordeaux, France
    AIDS 15:869-76. 2001
    ....
  42. doi request reprint Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients
    S Badiou
    Biochemistry Department, University Hospital of Montpellier, F 34295 Montpellier, France
    J Infect 57:47-54. 2008
    ..In addition, we studied the relationship between metabolic syndrome (MS) and CIMT...
  43. doi request reprint Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort
    Marc Arthur Loko
    INSERM, U593, Bordeaux, France
    Am J Gastroenterol 103:1973-80. 2008
    ..Although an increasing number of noninvasive fibrosis markers are available in HCV-monoinfected patients, data on the performance of these tests in HIV-HCV-coinfected patients are lacking...
  44. pmc Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
    Caroline A Sabin
    Lancet 371:1417-26. 2008
    ..Our aim was to explore whether exposure to such drugs was associated with an excess risk of myocardial infarction in a large, prospective observational cohort of HIV-infected patients...
  45. ncbi request reprint Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype
    L Castera
    Department of Hepatology, Hopital Haut Leveque, Centre Hospitalier Universitaire Bordeaux, Pessac, France
    Aliment Pharmacol Ther 26:1489-98. 2007
    ..Significance of steatosis in HIV-HCV coinfection remains controversial...
  46. ncbi request reprint [Cell culture for active Chlamydia trachomatis infection in a population of symptomatic women in Abidjan]
    H Bankole
    Laboratoire de Bacteriologie virologie, Institut Pasteur, Abidjan, Cote d Ivoire
    Bull Soc Pathol Exot 94:235-8. 2001
    ..206 samples gave no results because of blood or cervical mucus. During this study repeated contaminations of cells with facultative bacteria were noted and disposing of a sufficient number of cells was not easy...
  47. ncbi request reprint [Epidemiology of atherosclerotic cardiovascular risk in HIV-1 infected patients]
    R Thiebaut
    Institut de Santé Publique, d Épidémiologie et de Développement, INSERM U593, Universite Victor Segalen, Bordeaux 33
    Presse Med 32:1419-26. 2003
    ..The main risk factors seem to be classical risk factors such as smoking habits, age and dyslipidemia that are partly due themselves to highly active antiretroviral treatments..
  48. ncbi request reprint [Causes of fever in adults infected by HIV-1. Ambulatory follow-up in the ANRS 059 trial in Abidjan, Ivory Coast]
    N Dakoury-Dogbo
    CHU de Treichville, Programme PAC-CI, Abidjan
    Presse Med 30:1674-80. 2001
    ..The diffusion of antibiotic treatment algorithms adapted to the principle clinical syndromes encountered, might improve the treatment of adults infected by HIV consulting in sub-Saharian Africa...
  49. pmc 15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery
    L Mandelbrot
    Maternite Port Royal, Hopital Cochin, Paris, France UR091, Institut de Recherche pour le Développement IRD LPE, Marseille, France
    Sex Transm Infect 78:267-70. 2002
    ..To study mother to child HIV-1 transmission (MTCT) and infant mortality following benzalkonium chloride (BC) disinfection...
  50. ncbi request reprint Cardio- and cerebrovascular events in HIV-infected persons
    A d'Arminio
    Universita degli Studi di Milano, Italy
    AIDS 18:1811-7. 2004
    ..The present study was performed to investigate whether this risk was similar when including other cardio- and cerebro-vascular disease events (CCVE)...
  51. ncbi request reprint [The Ditrame (ANRS 049) clinical trial aimed at reducing the mother-child transmission of HIV in Abidjan. Participants' understanding of the trial principles]
    D Coulibaly-Traore
    Universite de Cocody, Abidjan, Cote d Ivoire
    Presse Med 32:343-50. 2003
    ..This study is aimed at describing the level of understanding and interpretations that these women have of the clinical trial, randomisation and placebo, as well as their motivations for participating in the study...
  52. pmc Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction
    C A Sabin
    Dept of Primary Care and Population Sciences, Royal Free and UC Medical School, Rowland Hill St, London, NW3 2PF, United Kingdom
    Clin Infect Dis 46:1101-10. 2008
    ..We evaluated changes in risk factors for CVD and the use of lipid-lowering therapy in HIV-infected individuals and assessed the impact of any changes on the incidence of myocardial infarction...